The global Next-Generation Sequencing (NGS) Services market size was valued at USD 3797 million in 2022 and is forecast to a readjusted size of USD 9940.1 million by 2029 with a CAGR of 14.7% during review period.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%. Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%. Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
This report is a detailed and comprehensive analysis for global Next-Generation Sequencing (NGS) Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Next-Generation Sequencing (NGS) Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Next-Generation Sequencing (NGS) Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Next-Generation Sequencing (NGS) Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Next-Generation Sequencing (NGS) Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next-Generation Sequencing (NGS) Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next-Generation Sequencing (NGS) Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths:
- Advanced technology enabling high-throughput sequencing, leading to faster and more accurate results.
- Expanding applications in personalized medicine, oncology, and genomics research, driving demand for NGS services.
Weaknesses:
- High costs associated with NGS technology and services, which may limit accessibility for smaller laboratories and healthcare facilities.
- Complexity of data interpretation and analysis requiring specialized skills and resources, potentially hindering market growth.
Opportunities:
- Increasing investment in genomics research and personalized medicine offers significant growth potential for NGS service providers.
- Rising prevalence of genetic disorders and cancers enhances the demand for NGS solutions in clinical diagnostics.
Threats:
- Intense competition among NGS service providers may lead to pricing pressures and reduced profit margins.
- Regulatory challenges and ethical concerns regarding genetic data privacy could impact market expansion and consumer trust.
Political:
- Government support for genomics research and healthcare funding can drive the adoption of NGS technologies.
- Regulatory policies related to genetic data privacy and ethical considerations could influence market dynamics.
Economic:
- Rising healthcare costs and increasing demand for precision medicine can fuel market growth for NGS services.
- Economic disparities and high service costs may limit NGS adoption in low- and middle-income countries.
Social:
- Growing awareness about personalized healthcare and genetic testing is expected to increase demand for NGS services.
- Public concerns over genetic data privacy may hinder wider acceptance of NGS-based services.
Technological:
- Continuous advancements in sequencing technologies, such as improvements in accuracy and speed, contribute to market expansion.
- Data interpretation challenges due to the complexity of genomic data may slow adoption despite technological progress.
Environmental:
- Sustainable practices in the production of NGS technology can enhance market appeal, especially among environmentally conscious consumers.
- Disposal of biohazardous materials related to genomic testing could lead to regulatory scrutiny and compliance costs.
Legal:
- Evolving legal frameworks surrounding genetic data and intellectual property rights can impact the growth of NGS services.
- Legal challenges related to the ownership and use of genetic data may create barriers for NGS companies in certain markets.
Suppliers:
- Technology providers offering advanced sequencing platforms and reagents are key to the NGS service market.
- Data storage and cloud computing companies providing infrastructure for managing large genomic datasets are crucial suppliers.
Inputs:
- High-quality DNA/RNA samples are essential for successful sequencing and accurate results.
- Advanced bioinformatics software and algorithms for data analysis and interpretation are required to process sequencing outputs.
Processes:
- DNA/RNA extraction, sequencing, and data analysis are the primary processes involved in NGS services.
- Quality control and validation procedures ensure the reliability and accuracy of sequencing results before delivery.
Outputs:
- Sequencing reports detailing genetic variants and mutations are delivered to clients, particularly for clinical applications.
- Data sets that contribute to scientific research, clinical diagnostics, and personalized medicine strategies are also key outputs.
Customers:
- Hospitals and diagnostic laboratories seeking genetic testing for personalized medicine, oncology, and rare diseases.
- Research institutions and pharmaceutical companies utilizing NGS for genomics studies and drug development.
Threat of New Entrants:
- High capital investment required for advanced sequencing technology and infrastructure acts as a barrier to new entrants.
- Strong brand presence and customer loyalty of established players in the NGS market make it difficult for new companies to gain market share.
Bargaining Power of Suppliers:
- Limited number of suppliers for specialized sequencing platforms and reagents increases supplier power in the market.
- Technological advancements from key suppliers can significantly impact the pricing and availability of sequencing services.
Bargaining Power of Buyers:
- As NGS services become more widely available, buyers (hospitals, clinics) have increased bargaining power to demand lower prices and better service quality.
- Large institutions with high-volume sequencing needs can negotiate favorable pricing, reducing the bargaining power of service providers.
Threat of Substitutes:
- Alternative diagnostic technologies like PCR and microarrays, while not as advanced, can serve as lower-cost substitutes in some cases.
- Emerging gene-editing technologies, such as CRISPR, could reduce the reliance on NGS services for certain genetic research applications.
Industry Rivalry:
- The presence of numerous well-established companies offering NGS services leads to intense competition for market share.
- Continuous innovation and technological advancements drive competitive rivalry, as companies strive to offer more accurate, faster, and cost-effective solutions.
Raw Materials:
- High-quality biological samples (DNA/RNA) from patients or research subjects are critical for NGS services, influencing the quality of results.
- Advanced reagents and consumables, such as primers, enzymes, and sequencing kits, are essential for the sequencing process.
Technology Providers:
- Sequencing platform manufacturers like Illumina, Thermo Fisher, and Oxford Nanopore are key upstream players, driving innovation in sequencing technologies.
- Bioinformatics software providers play a crucial role in the analysis and interpretation of genomic data generated by NGS systems.
Suppliers of Data Infrastructure:
- Cloud computing and data storage companies are important upstream suppliers, offering scalable solutions to store and process vast genomic datasets.
- Companies providing cybersecurity solutions to protect sensitive genetic data from breaches are increasingly important as data privacy concerns grow.
Regulatory Environment:
- Regulatory bodies like the FDA and EMA influence the upstream market by setting standards for NGS technology, data privacy, and clinical applications.
- Certification requirements for reagents, sequencing platforms, and data processing systems can affect the cost and availability of upstream supplies.
Sequencing Process:
- The sequencing process, including DNA/RNA extraction, library preparation, and actual sequencing, is the core of NGS services and involves advanced technologies like Illumina and PacBio.
- Efficient workflow management and high-throughput sequencing capabilities are critical to reducing turnaround times and improving service scalability.
Data Analysis and Interpretation:
- Bioinformatics tools for data processing, variant calling, and genomic analysis play a crucial role in translating raw sequencing data into clinically relevant insights.
- Data quality control, error correction, and reproducibility are essential for providing reliable results to healthcare providers and researchers.
Quality Control:
- Quality assurance protocols, including validation of sequencing runs and data accuracy, are critical for maintaining high standards in NGS services.
- The integration of automated quality control systems helps reduce human error and ensures consistency across sequencing batches.
Customer Engagement:
- Direct interactions with healthcare providers, research institutions, and pharmaceutical companies are key for understanding client requirements and tailoring NGS services.
- Establishing strong partnerships with hospitals and diagnostic centers can drive demand for clinical applications such as personalized medicine and oncology diagnostics.
Market Segments:
- Clinical diagnostics, particularly in oncology, rare diseases, and personalized medicine, is a rapidly growing downstream segment for NGS services.
- Research applications in genomics, drug development, and epidemiology also represent significant downstream demand for NGS data and insights.
End Users:
- Hospitals, diagnostic laboratories, and healthcare providers rely on NGS services for genetic testing and personalized treatment strategies.
- Pharmaceutical companies and biotech firms use NGS services for drug discovery, biomarker development, and clinical trials to advance precision medicine.
Distribution Channels:
- Direct sales and partnerships with hospitals and research institutions are critical for delivering NGS services to clinical end-users.
- Online platforms and cloud-based services for genomic data storage and analysis are becoming key distribution channels, particularly for research-focused clients.
Post-Service Support:
- Data interpretation and consultation services are increasingly important for helping clinicians and researchers understand complex genomic results.
- Ongoing software updates, training, and support are necessary to ensure optimal use of NGS technology and maintain customer satisfaction.
Chapter 1, to describe Next-Generation Sequencing (NGS) Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Sequencing (NGS) Services, with revenue, gross margin and global market share of Next-Generation Sequencing (NGS) Services from 2018 to 2023.
Chapter 3, the Next-Generation Sequencing (NGS) Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Next-Generation Sequencing (NGS) Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Sequencing (NGS) Services.
Chapter 13, to describe Next-Generation Sequencing (NGS) Services research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Next-Generation Sequencing (NGS) Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next-Generation Sequencing (NGS) Services by Type
1.3.1 Overview: Global Next-Generation Sequencing (NGS) Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Type in 2022
1.3.3 Targeted Sequencing
1.3.4 Whole Exome Sequencing
1.3.5 Whole Genome Sequencing
1.4 Global Next-Generation Sequencing (NGS) Services Market by Application
1.4.1 Overview: Global Next-Generation Sequencing (NGS) Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Biopharma Companies
1.4.4 Academic & Research Organizations
1.4.5 Others
1.5 Global Next-Generation Sequencing (NGS) Services Market Size & Forecast
1.6 Global Next-Generation Sequencing (NGS) Services Market Size and Forecast by Region
1.6.1 Global Next-Generation Sequencing (NGS) Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Next-Generation Sequencing (NGS) Services Market Size by Region, (2018-2029)
1.6.3 North America Next-Generation Sequencing (NGS) Services Market Size and Prospect (2018-2029)
1.6.4 Europe Next-Generation Sequencing (NGS) Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size and Prospect (2018-2029)
1.6.6 South America Next-Generation Sequencing (NGS) Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Next-Generation Sequencing (NGS) Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Eurofins Scientific
2.1.1 Eurofins Scientific Details
2.1.2 Eurofins Scientific Major Business
2.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product and Solutions
2.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Eurofins Scientific Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera Next-Generation Sequencing (NGS) Services Product and Solutions
2.2.4 Natera Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Natera Recent Developments and Future Plans
2.3 BGI
2.3.1 BGI Details
2.3.2 BGI Major Business
2.3.3 BGI Next-Generation Sequencing (NGS) Services Product and Solutions
2.3.4 BGI Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BGI Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Next-Generation Sequencing (NGS) Services Product and Solutions
2.4.4 Illumina Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Next-Generation Sequencing (NGS) Services Product and Solutions
2.5.4 Roche Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Roche Recent Developments and Future Plans
2.6 LabCorp
2.6.1 LabCorp Details
2.6.2 LabCorp Major Business
2.6.3 LabCorp Next-Generation Sequencing (NGS) Services Product and Solutions
2.6.4 LabCorp Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 LabCorp Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Product and Solutions
2.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Brooks Life Sciences
2.8.1 Brooks Life Sciences Details
2.8.2 Brooks Life Sciences Major Business
2.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product and Solutions
2.8.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Brooks Life Sciences Recent Developments and Future Plans
2.9 Macrogen
2.9.1 Macrogen Details
2.9.2 Macrogen Major Business
2.9.3 Macrogen Next-Generation Sequencing (NGS) Services Product and Solutions
2.9.4 Macrogen Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Macrogen Recent Developments and Future Plans
2.10 Personalis
2.10.1 Personalis Details
2.10.2 Personalis Major Business
2.10.3 Personalis Next-Generation Sequencing (NGS) Services Product and Solutions
2.10.4 Personalis Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Personalis Recent Developments and Future Plans
2.11 Novogene
2.11.1 Novogene Details
2.11.2 Novogene Major Business
2.11.3 Novogene Next-Generation Sequencing (NGS) Services Product and Solutions
2.11.4 Novogene Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novogene Recent Developments and Future Plans
2.12 Genotypic Technology
2.12.1 Genotypic Technology Details
2.12.2 Genotypic Technology Major Business
2.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Product and Solutions
2.12.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Genotypic Technology Recent Developments and Future Plans
2.13 Dna Link
2.13.1 Dna Link Details
2.13.2 Dna Link Major Business
2.13.3 Dna Link Next-Generation Sequencing (NGS) Services Product and Solutions
2.13.4 Dna Link Next-Generation Sequencing (NGS) Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Dna Link Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Next-Generation Sequencing (NGS) Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Next-Generation Sequencing (NGS) Services by Company Revenue
3.2.2 Top 3 Next-Generation Sequencing (NGS) Services Players Market Share in 2022
3.2.3 Top 6 Next-Generation Sequencing (NGS) Services Players Market Share in 2022
3.3 Next-Generation Sequencing (NGS) Services Market: Overall Company Footprint Analysis
3.3.1 Next-Generation Sequencing (NGS) Services Market: Region Footprint
3.3.2 Next-Generation Sequencing (NGS) Services Market: Company Product Type Footprint
3.3.3 Next-Generation Sequencing (NGS) Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Next-Generation Sequencing (NGS) Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Next-Generation Sequencing (NGS) Services Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Next-Generation Sequencing (NGS) Services Market Forecast by Application (2024-2029)
6 North America
6.1 North America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2029)
6.2 North America Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2029)
6.3 North America Next-Generation Sequencing (NGS) Services Market Size by Country
6.3.1 North America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2029)
6.3.2 United States Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
6.3.3 Canada Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2029)
7.2 Europe Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2029)
7.3 Europe Next-Generation Sequencing (NGS) Services Market Size by Country
7.3.1 Europe Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2029)
7.3.2 Germany Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
7.3.3 France Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
7.3.5 Russia Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
7.3.6 Italy Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Region
8.3.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Region (2018-2029)
8.3.2 China Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
8.3.3 Japan Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
8.3.5 India Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
8.3.7 Australia Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2029)
9.2 South America Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2029)
9.3 South America Next-Generation Sequencing (NGS) Services Market Size by Country
9.3.1 South America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country
10.3.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
10.3.4 UAE Next-Generation Sequencing (NGS) Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Next-Generation Sequencing (NGS) Services Market Drivers
11.2 Next-Generation Sequencing (NGS) Services Market Restraints
11.3 Next-Generation Sequencing (NGS) Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Next-Generation Sequencing (NGS) Services Industry Chain
12.2 Next-Generation Sequencing (NGS) Services Upstream Analysis
12.3 Next-Generation Sequencing (NGS) Services Midstream Analysis
12.4 Next-Generation Sequencing (NGS) Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Next-Generation Sequencing (NGS) Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Next-Generation Sequencing (NGS) Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Next-Generation Sequencing (NGS) Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Next-Generation Sequencing (NGS) Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 6. Eurofins Scientific Major Business
Table 7. Eurofins Scientific Next-Generation Sequencing (NGS) Services Product and Solutions
Table 8. Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Eurofins Scientific Recent Developments and Future Plans
Table 10. Natera Company Information, Head Office, and Major Competitors
Table 11. Natera Major Business
Table 12. Natera Next-Generation Sequencing (NGS) Services Product and Solutions
Table 13. Natera Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Natera Recent Developments and Future Plans
Table 15. BGI Company Information, Head Office, and Major Competitors
Table 16. BGI Major Business
Table 17. BGI Next-Generation Sequencing (NGS) Services Product and Solutions
Table 18. BGI Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. BGI Recent Developments and Future Plans
Table 20. Illumina Company Information, Head Office, and Major Competitors
Table 21. Illumina Major Business
Table 22. Illumina Next-Generation Sequencing (NGS) Services Product and Solutions
Table 23. Illumina Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Illumina Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Next-Generation Sequencing (NGS) Services Product and Solutions
Table 28. Roche Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Roche Recent Developments and Future Plans
Table 30. LabCorp Company Information, Head Office, and Major Competitors
Table 31. LabCorp Major Business
Table 32. LabCorp Next-Generation Sequencing (NGS) Services Product and Solutions
Table 33. LabCorp Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. LabCorp Recent Developments and Future Plans
Table 35. Berry Genomics Company Information, Head Office, and Major Competitors
Table 36. Berry Genomics Major Business
Table 37. Berry Genomics Next-Generation Sequencing (NGS) Services Product and Solutions
Table 38. Berry Genomics Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Berry Genomics Recent Developments and Future Plans
Table 40. Brooks Life Sciences Company Information, Head Office, and Major Competitors
Table 41. Brooks Life Sciences Major Business
Table 42. Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product and Solutions
Table 43. Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Brooks Life Sciences Recent Developments and Future Plans
Table 45. Macrogen Company Information, Head Office, and Major Competitors
Table 46. Macrogen Major Business
Table 47. Macrogen Next-Generation Sequencing (NGS) Services Product and Solutions
Table 48. Macrogen Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Macrogen Recent Developments and Future Plans
Table 50. Personalis Company Information, Head Office, and Major Competitors
Table 51. Personalis Major Business
Table 52. Personalis Next-Generation Sequencing (NGS) Services Product and Solutions
Table 53. Personalis Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Personalis Recent Developments and Future Plans
Table 55. Novogene Company Information, Head Office, and Major Competitors
Table 56. Novogene Major Business
Table 57. Novogene Next-Generation Sequencing (NGS) Services Product and Solutions
Table 58. Novogene Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Novogene Recent Developments and Future Plans
Table 60. Genotypic Technology Company Information, Head Office, and Major Competitors
Table 61. Genotypic Technology Major Business
Table 62. Genotypic Technology Next-Generation Sequencing (NGS) Services Product and Solutions
Table 63. Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Genotypic Technology Recent Developments and Future Plans
Table 65. Dna Link Company Information, Head Office, and Major Competitors
Table 66. Dna Link Major Business
Table 67. Dna Link Next-Generation Sequencing (NGS) Services Product and Solutions
Table 68. Dna Link Next-Generation Sequencing (NGS) Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Dna Link Recent Developments and Future Plans
Table 70. Global Next-Generation Sequencing (NGS) Services Revenue (USD Million) by Players (2018-2023)
Table 71. Global Next-Generation Sequencing (NGS) Services Revenue Share by Players (2018-2023)
Table 72. Breakdown of Next-Generation Sequencing (NGS) Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Next-Generation Sequencing (NGS) Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Next-Generation Sequencing (NGS) Services Players
Table 75. Next-Generation Sequencing (NGS) Services Market: Company Product Type Footprint
Table 76. Next-Generation Sequencing (NGS) Services Market: Company Product Application Footprint
Table 77. Next-Generation Sequencing (NGS) Services New Market Entrants and Barriers to Market Entry
Table 78. Next-Generation Sequencing (NGS) Services Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Next-Generation Sequencing (NGS) Services Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Next-Generation Sequencing (NGS) Services Consumption Value Share by Type (2018-2023)
Table 81. Global Next-Generation Sequencing (NGS) Services Consumption Value Forecast by Type (2024-2029)
Table 82. Global Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2023)
Table 83. Global Next-Generation Sequencing (NGS) Services Consumption Value Forecast by Application (2024-2029)
Table 84. North America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Next-Generation Sequencing (NGS) Services Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Next-Generation Sequencing (NGS) Services Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Next-Generation Sequencing (NGS) Services Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Next-Generation Sequencing (NGS) Services Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Next-Generation Sequencing (NGS) Services Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Next-Generation Sequencing (NGS) Services Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Next-Generation Sequencing (NGS) Services Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Next-Generation Sequencing (NGS) Services Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Next-Generation Sequencing (NGS) Services Raw Material
Table 115. Key Suppliers of Next-Generation Sequencing (NGS) Services Raw Materials
List of Figures
Figure 1. Next-Generation Sequencing (NGS) Services Picture
Figure 2. Global Next-Generation Sequencing (NGS) Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Type in 2022
Figure 4. Targeted Sequencing
Figure 5. Whole Exome Sequencing
Figure 6. Whole Genome Sequencing
Figure 7. Global Next-Generation Sequencing (NGS) Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Application in 2022
Figure 9. Hospitals and Clinics Picture
Figure 10. Biopharma Companies Picture
Figure 11. Academic & Research Organizations Picture
Figure 12. Others Picture
Figure 13. Global Next-Generation Sequencing (NGS) Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Next-Generation Sequencing (NGS) Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Next-Generation Sequencing (NGS) Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Region in 2022
Figure 18. North America Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Next-Generation Sequencing (NGS) Services Revenue Share by Players in 2022
Figure 24. Next-Generation Sequencing (NGS) Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Next-Generation Sequencing (NGS) Services Market Share in 2022
Figure 26. Global Top 6 Players Next-Generation Sequencing (NGS) Services Market Share in 2022
Figure 27. Global Next-Generation Sequencing (NGS) Services Consumption Value Share by Type (2018-2023)
Figure 28. Global Next-Generation Sequencing (NGS) Services Market Share Forecast by Type (2024-2029)
Figure 29. Global Next-Generation Sequencing (NGS) Services Consumption Value Share by Application (2018-2023)
Figure 30. Global Next-Generation Sequencing (NGS) Services Market Share Forecast by Application (2024-2029)
Figure 31. North America Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 41. France Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Region (2018-2029)
Figure 48. China Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 51. India Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Next-Generation Sequencing (NGS) Services Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Next-Generation Sequencing (NGS) Services Consumption Value (2018-2029) & (USD Million)
Figure 65. Next-Generation Sequencing (NGS) Services Market Drivers
Figure 66. Next-Generation Sequencing (NGS) Services Market Restraints
Figure 67. Next-Generation Sequencing (NGS) Services Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Next-Generation Sequencing (NGS) Services in 2022
Figure 70. Manufacturing Process Analysis of Next-Generation Sequencing (NGS) Services
Figure 71. Next-Generation Sequencing (NGS) Services Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
